fda glp-1 enforcement news today The growing availability of compounded weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. https://www.wfla.com/bloom-tampa-bay/bloom-health-and-wellness/compounded- glp-1-drugs-creating-concern-among Novo Nordisk expands legal action

Signs & Symptoms: Changes in Moles to Look Out for Once a mole has appeared, it is very difficult to predict how it might change over time

A: As of March 2026, GHK-Cu and other peptides previously on the FDAs Category 2 restricted list are expected to be reclassified to Category 1, which would restore legal access through licensed compounding pharmacies

Taking too much thyroid hormone may be especially common in people with subclinical hypothyroidism who probably dont need thyroid hormone replacement 1 2

When Mounjaro Should Strictly Be Avoided Altogether While Mounjaro is generally effective for some, it is not safe to use with other medications and could potentially harm your body

Meaningful weight loss typically becomes apparent over the first three to six months, with continued progress over the following year